New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


Parkinson's news

Global update

Parkinson’s in the news: January

A roundup of Parkinson’s news stories in January

READ MORE

Perspectives

Who said what: QoTW 25.06.15

Our favourite quotes of the week from around the web

READ MORE
Natasha McCarthy and family

Perspectives

World Parkinson Congress 2019 Bloggers: Natasha McCarthy

#WPC2019: We talk to Canadian blogger Natasha McCarthy

READ MORE